CTLA4 and rheumatoid arthritis: Moreover, in the assessment of the possible predictive power of putative biomarkers of treatment response to CTLA4-Ig in the whole RA cohort, ROC curve analysis identified baseline IL-6 serum levels significantly discriminating, at pre-treatment stage, RA patients achieving DAS remission within 6 months.